4. As of noon trading, Allergan ( AGN) is up $1.20 (1.4%) to $86.86 on average volume. Thus far, 1.5 million shares of Allergan exchanged hands as compared to its average daily volume of 2.8 million shares. The stock has ranged in price between $85.83-$87.62 after having opened the day at $86.09 as compared to the previous trading day's close of $85.65.

Allergan, Inc. operates as a multi-specialty healthcare company primarily in the United States, Europe, Latin America, and the Asia Pacific. Allergan has a market cap of $25.0 billion and is part of the drugs industry. Shares are down 6.6% year to date as of the close of trading on Monday. Currently there are 12 analysts that rate Allergan a buy, no analysts rate it a sell, and 12 rate it a hold.

TheStreet Ratings rates Allergan as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, expanding profit margins and notable return on equity. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full Allergan Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

If you liked this article you might like

Wireless Carriers Offer Deals to Connect Apple Watch 3 to Their Networks

Apple's Next Big Ambition Might Not Generate Any Revenue Just Yet

Here's How Apple Could Surprise Us With an Improved Apple Watch

How Much Trouble is Aetna in After Its HIV Status Breach?

Healthcare Management Stocks Look Too Pricey for Activists